Inve US ▾
AXAXTI

AXT (AXTI) Q2 FY26 earnings call: guidance and Q&A

Earnings call· Jun 2026 (Q2 FY26)· Information Technology· Jul 30, 2026

Source: earnings call transcript

Executive summary

AXT Q2 FY26 — Record Revenue and Indium Phosphide Growth

AXT achieved record revenue in Q2 FY26, driven by unprecedented demand for indium phosphide in AI data center applications, leading to a significant return to profitability. The company is aggressively expanding indium phosphide capacity, with plans to more than triple by year-end and double again in 2027, though demand continues to outpace supply. The IPO plan for its Tongmei subsidiary has shifted to the Hong Kong Exchange.

Highlights

5
  • Revenue reached $47.6 million, the highest quarterly revenue in AXT's history, up 77% QoQ and 164% YoY.

  • Indium phosphide revenue hit a record $30.7 million, primarily driven by data center applications.

  • Non-GAAP gross margin improved substantially to 45.0% from 29.9% in Q1 FY26 and 8.2% in Q2 FY25.

  • The company returned to profitability with a non-GAAP net profit of $11.9 million, or $0.19 per diluted share.

  • Indium phosphide capacity is on track to more than triple by the end of 2026, with significant expansion expected in 2027.

Concerns

3
  • Tongmei's IPO application shifted from the STAR market to the Hong Kong Exchange, creating a redemption right for $49 million invested by PE funds.

  • Customer demand continues to outpace supply, despite rapid capacity expansion efforts.

  • Permit timing and certainty for export remain unpredictable, though regularity in the process is improving.

Guidance & targets

CategoryTargetConfidence
Revenue
$66 million
high materiality
High
Non-GAAP Net Income per diluted share
$0.30 to $0.32
high materiality
Medium
GAAP Net Income per diluted share
$0.29 to $0.31
high materiality
Medium
Non-GAAP Operating Expense
approximately $10.5 million
medium materiality
Medium
GAAP Operating Expense
approximately $11 million
medium materiality
Medium
Diluted Shares Outstanding
approximately 66.5 million shares
low materiality
Medium
Indium Phosphide Capacity (revenue equivalent)
more than triple
high materiality
High
Indium Phosphide Capacity (revenue equivalent)
double again
high materiality
High
Indium Phosphide Capacity (revenue equivalent)
somewhere in the region of about $60 million a quarter
high materiality
High
Indium Phosphide Capacity (revenue equivalent)
somewhere in the region of about $130 million a quarter
high materiality
High
Gross Margin
a number that begins with the 5
high materiality
Medium

Segment performance

SegmentRevenueYoYQoQMargin
Indium Phosphide
Primarily from data center applications.
Highest in company history
$30.7 million———
Gallium Arsenide
Demand for semiconducting wafers for industrial robotics and data center laser applications grew sequentially.
$6.6 million—sequentially grew—
Germanium
$272,000———
Consolidated Raw Material Joint Ventures
Highly strategic to growth plan.
Record third quarter revenue
$10.0 million———

Orderbook & backlog

Backlog well over $100 million Q2 FY26

continues to grow

Exceeds 2 quarters; extends out 3 or 4 quarters with long-term supply agreements; company is selective in taking orders due to capacity constraints.

Deals & partnerships

Casela Long-term supply agreement for wafers $22.3 million

Agreement includes significant upfront cash prepayment for wafers. Supply starts in 2027.

Coherent Long-term supply agreement for wafers $25.4 million

Agreement includes significant upfront cash prepayment for wafers.

Lumentum Agreement (implied long-term supply agreement)

Agreement announced this week, deepens relationship with an important customer.

Capital programs

Indium Phosphide Capacity Expansion underway
Period spend: not a lot of additional CapEx spend here
Spent to date: ahead of schedule
Start: 2026

Benefit:more than triple by end of 2026, double again in 2027; make AXT by far the largest indium phosphide producer in the world

Committed to doubling 2026 capacity, now on track to more than triple by year-end, with further doubling planned for 2027. This is driven by new furnace designs, productivity, and product mix, not just CapEx.

Risks & headwinds

Permit timing and certainty for export Ongoing, Q3 FY26

Cannot predict the future timing of permits or success in obtaining them for any specific customer or individual order. Could impact realization of upside revenue.

Mitigation:Seeing more regularity in the process, especially in certain geographic regions; driving more permit applications through the Ministry of Commerce.

Tongmei IPO shift to Hong Kong Exchange Likely take about a year to complete

Creates a redemption right for the $49 million invested by PE funds back in 2021.

Mitigation:Discussions with PE funds indicate they wish to continue investment; company has sufficient cash to redeem if requested.

Customer demand outpacing supply Ongoing

Customer demand continues to outpace supply no matter how fast we add capacity.

Mitigation:Aggressive capacity expansion, accelerating physical capacity, improving manufacturing productivity, moving to larger diameter substrates.

What to watch in Q3 FY26

Indium Phosphide Capacity Expansion

End of 2026
Current Ahead of schedule for doubling in 2026, on track to more than triple by end of 2026.
Target Continued acceleration towards $60M/quarter revenue equivalent capacity by end of 2026.

Why it matters

This is the primary driver for revenue growth and market share in the high-demand AI data center market.

We have committed to doubling our indium phosphide capacity in 2026, and I'm pleased to report that we are ahead of the schedule in that effort. But more importantly, I can now report to you that our revenue opportunity for indium phosphide is on track to more than triple by the end of 2026, with continued significant expansion expected in 2027.

Find out whether AXTI delivers this. Inve re-checks your case every morning.

Q&A highlights

Clarification on the new indium phosphide capacity targets for end of 2026 and 2027, and details on the Lumentum supply agreement.

Confirmed indium phosphide capacity equivalent to $60 million per quarter by end of 2026 and $130 million per quarter by end of 2027. Did not disclose the total revenue impact of the Lumentum deal but noted prepayments.

“Yes, that's about right, Tim. That's exactly what we're looking at here. About $60 million there thereabouts.”

asked by Timothy Savageaux · answered by Timothy Bettles

2 min read 6 chapters

Detailed narrative

Record Indium Phosphide Demand

AXT reported its highest quarterly revenue of $47.6 million, with indium phosphide revenue reaching a record $30.7 million, primarily driven by AI data center applications. The company is experiencing an inflection point with extremely strong customer demand for its indium phosphide material, leading to a significant return to profitability with a non-GAAP net profit of $11.9 million.

Aggressive Capacity Expansion

The company is ahead of schedule in doubling its indium phosphide capacity in 2026 and plans to more than triple it by year-end, with further doubling expected in 2027. This expansion is supported by new crystal-growing furnace designs, increased manufacturing productivity, and a shift to larger diameter substrates and higher-value products, which are driving a step function increase in revenue.

Strategic Long-Term Agreements

AXT signed strategic long-term supply agreements with Casela, Coherent, and Lumentum. These agreements include significant prepayments for wafers ($22.3 million from Casela, $25.4 million from Coherent) and deepen customer relationships, providing conviction for the ongoing capacity build-out. These partnerships highlight the critical role of indium phosphide in high-speed optical data transmission for AI data centers.

China Market Growth and IPO Shift

China's investment in AI infrastructure is driving significant growth, with indium phosphide-based laser market revenue in China more than doubling quarter-over-quarter in Q2. While the Tongmei IPO application was moved from the STAR market to the Hong Kong Exchange, the company views this as beneficial for expanding capacity and supporting AI infrastructure in China, despite creating a redemption right for $49 million in PE funds.

Gross Margin Improvement Drivers

Gross margin saw substantial improvement to 45.0% non-GAAP, driven by increased total volume and a favorable product mix, particularly the higher contribution from indium phosphide. Management anticipates further margin expansion due to continued volume growth, productivity gains, and the migration to larger diameter substrates, with a target of reaching margins that begin with a '5'.

Raw Material Vertical Integration

The raw material joint venture companies contributed $10.0 million in revenue. The subsidiary Jin Mei is now refining high-purity indium, providing direct control over a critical supply chain component for indium phosphide substrates. This unique integrated supply chain is considered a major competitive differentiator, with ongoing investments to expand Jin Mei's capabilities.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.